Prevention program for Clostridium difficile infection: a single-centre Serbian experience

被引:1
|
作者
Brkic, Snezana [1 ]
Pellicano, Rinaldo [2 ]
Turkulov, Vesna [1 ]
Radovanovic, Marija [3 ]
Abenavoli, Ludovico [4 ]
机构
[1] Univ Novi Sad, Med Fac Novi Sad, Clin Ctr Vojvodina Infect Dis, Novi Sad, Serbia
[2] Molinette Mauriziano Hosp, Dept Gastrohepatol, Turin, Italy
[3] Miofarm Doo, Novi Sad, Serbia
[4] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy
关键词
Clostridium dffficile; Infection; Prevention and control; Hospitals; ECONOMIC BURDEN; DISEASE; EPIDEMIOLOGY; COSTS; MANAGEMENT; DIAGNOSIS; DIARRHEA; HOSPITALS; EUROPE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Clostridium difficile (C. difficile) diarrhea is a common, iatrogenic, nosocomial disease with a worldwide diffusion. Recent studies reported that the incidence of C. difficile infection (CDI) is rising, due to aging of the population and to greater prevalence of hypervirulent strains. We investigated whether the application of a prevention program lead to a decline in the incidence of intrahospital CDI. METHODS: The study was designed as observational, to compare the efficacy of Schillke preventive program with the standard protocols, in a period of 4 months. For every patient with community-onset healthcare facility-associated (HCFA) CDI, we randomly selected four controls (1:4) with the same ICD code but without HCFA CDI. For statistical analysis the nonparametric, one-way ANOVA, univariate regression analysis, univariate analysis of variance, and Welch and Brown-Forsythe Test were used. RESULTS: Clinical features of HCFA CDI were typical. HCFA CDI group was significantly older than control group (P=0.008 and F=6.686; Partial Eta Square=0.013). Patients with HCFA CDI stayed significantly longer in hospital (P=0.000 and F=69.379; Partial Eta Square=0.117). Acquiring CDI prolonged the hospitalization of 14.52 days. HCFA CDI significantly increases the total cost of hospitalization as well as each element of the price respectively. With the application of the prevention program the annual incidence of CDI dropped from 49.01 in 2013 to 18.22/10000 bed days in 2014. CONCLUSIONS: Applying Schulke preventive program, implemented in 2014, has led to significant savings for the hospital compared to previous methods.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [21] Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
    Wilcox, M. H.
    Gerding, D. N.
    Poxton, I. R.
    Kelly, C.
    Nathan, R.
    Birch, T.
    Cornely, O. A.
    Rahav, G.
    Bouza, E.
    Lee, C.
    Jenkin, G.
    Jensen, W.
    Kim, Y. -S.
    Yoshida, J.
    Gabryelski, L.
    Pedley, A.
    Eves, K.
    Tipping, R.
    Guris, D.
    Kartsonis, N.
    Dorr, M. -B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (04): : 305 - 317
  • [22] The Impact of Recurrent Clostridium difficile Infection on Patients' Prevention Behaviors
    Weaver, Frances M.
    Trick, William E.
    Evans, Charlesnika T.
    Lin, Michael Y.
    Adams, William
    Pho, Mai T.
    Bleasdale, Susan C.
    Mullane, Kathleen M.
    Johnson, Stuart
    Sikka, Monica K.
    Peterson, Lance R.
    Solomonides, Anthony E.
    Gerding, Dale N.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2017, 38 (11): : 1351 - 1357
  • [23] Clostridium difficile Infection: Epidemiology, Clinical Presentation, Therapy and Prevention
    Kaffarnik, Magnus
    Isner, Caroline
    Hamsen, Uwe
    ZENTRALBLATT FUR CHIRURGIE, 2018, 143 (03): : 241 - 249
  • [24] Community-acquired Clostridium difficile infection in Serbian pediatric population
    Stojanović Predrag
    Kocić Branislava
    Stojanović Nikola
    Radulovic Niko
    Stojanović-Radić Zorica
    Dobrila Stanković-Đorđević
    European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1061 - 1069
  • [25] Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection
    Stevens, Vanessa W.
    Nelson, Richard E.
    Schwab-Daugherty, Elyse M.
    Khader, Karim
    Jones, Makoto M.
    Brown, Kevin A.
    Greene, Tom
    Croft, Lindsay D.
    Neuhauser, Melinda
    Glassman, Peter
    Goetz, Matthew Bidwell
    Samore, Matthew H.
    Rubin, Michael A.
    JAMA INTERNAL MEDICINE, 2017, 177 (04) : 546 - 553
  • [26] Extraintestinal Clostridium difficile Infections: A Single-Center Experience
    Gupta, Arjun
    Patel, Robin
    Baddour, Larry M.
    Pardi, Darrell S.
    Khanna, Sahil
    MAYO CLINIC PROCEEDINGS, 2014, 89 (11) : 1525 - 1536
  • [27] Prevention of Healthcare-Associated Clostridium difficile Infection: What Works?
    Dubberke, Erik R.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 : S38 - S41
  • [28] Enterocutaneous fistula: a single-centre experience
    Gyorki, D. E.
    Brooks, C. E.
    Gett, R.
    Woods, R. J.
    Johnston, M.
    Keck, J. O.
    Mackay, J. R.
    Heriot, A. G.
    ANZ JOURNAL OF SURGERY, 2010, 80 (03) : 178 - 181
  • [29] Pituitary incidentalomas: a single-centre experience
    Anagnostis, P.
    Adamidou, F.
    Polyzos, S. A.
    Efstathiadou, Z.
    Panagiotou, A.
    Kita, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (02) : 172 - 177
  • [30] Liver retransplantation: a single-centre experience
    Ma Yi
    Wang Guo-Dong
    He Xiao-Shun
    Li Jun-Liang
    CHINESE MEDICAL JOURNAL, 2008, 121 (20) : 1987 - 1991